본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review Cho, Hyunsoon
(Department of Cancer Control and Population Health)

Tran Thi Xuan Mai
(Department of Cancer Control and Population Health)
. Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review. SUPPORTIVE CARE IN CANCER. 2020-10-15; 2020; Online:Published. IF 2.635 (2019)
IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer
()

Rho Seung Bae
(Division of Translational Science)
. IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020-10-15; 2020; 21(20):7622~. IF 4.556 (2019)
Association between early treatment hospitals, serum cholesterol level and cardiovascular disease risk in dyslipidemia patients
()

Han Kyu Tae
(Division of Cancer Management Policy)
. Association between early treatment hospitals, serum cholesterol level and cardiovascular disease risk in dyslipidemia patients. EUROPEAN JOURNAL OF PUBLIC HEALTH. 2020-10-10; 2020; Online:Published. IF 2.391 (2019)
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial Park Joong-Won
(Division of Clinical Research)

Kim, Tae Hyun
(Division of Convergence Technology)
. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial. JOURNAL OF HEPATOLOGY. 2020-10-05; 2020; S0168-8278(20):33670-9~. IF 20.582 (2019)
The Different Clinicopathological Features of Remnant Gastric Cancer Depending on Initial Disease of Partial Gastrectomy Kook Myeong-Cherl
(Division of Translational Science)

Han Won Ho
(Intensive Care Unit)
. The Different Clinicopathological Features of Remnant Gastric Cancer Depending on Initial Disease of Partial Gastrectomy. CANCERS. 2020-10-02; 2020; 12(10):E2847~. IF 6.126 (2019)
Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study Seo Ho Kyung
(Division of Tomor Immunology)


()
. Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study. FRONTIERS IN ONCOLOGY. 2020-10-02; 2020; 10:568809~. IF 4.848 (2019)
Novel robot-assisted thyroidectomy by a transaxillary gasinsufflation approach (TAGA): a preliminary report Jung Yuh Seog
(Department of Otorhinolaryngology)

Seok Jun Girl
(Department of Otorhinolaryngology)
. Novel robot-assisted thyroidectomy by a transaxillary gasinsufflation approach (TAGA): a preliminary report. GLAND SURGERY. 2020-10-01; 2020; 9(5):1267~1277. IF 2.19 (2019)
Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer Kook Myeong-Cherl
(Division of Translational Science)

Ryu Keun Won
(Division of Clinical Research)
. Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer. CHINESE JOURNAL OF CANCER RESEARCH. 2020-10-01; 2020; 32(5):614~620. IF 4.135 (2019)
Distinct metabolic preference of atypical KRAS mutant Cheong Heesun
(Division of Cancer Branch)

Cheong Heesun
(Division of Cancer Branch)
. Distinct metabolic preference of atypical KRAS mutant. ANNALS OF TRANSLATIONAL MEDICINE. 2020-10-01; 2020; 8(20):1326~. IF 3.297 (2019)
A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
()

Lee Eun Kyung
(Division of Translational Science)
. A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol. ENDOCRINOLOGY AND METABOLISM. 2020-09-30; 2020; 35(3):571~577. IF 3.257 (2019)
First page Prev paging 131 132 133 134 135 136 137 138 139 140 next paging last page